| YMAB |
Y-mAbs Therapeutics, Inc. |
16 Sep 2025 |
1 |
-$39,209,404 |
4 |
Director, 10%+ Owner |
18 Sep 2025, 21:39 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
11 Dec 2023 |
1 |
+$44,232 |
4 |
Director |
12 Dec 2023, 08:27 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
07 Dec 2023 |
3 |
+$890,411 |
4 |
Director |
11 Dec 2023, 17:25 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
29 Nov 2023 |
1 |
+$309,477 |
4 |
Director |
01 Dec 2023, 17:15 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
27 Nov 2023 |
2 |
+$521,294 |
4 |
Director |
29 Nov 2023, 17:14 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
15 May 2023 |
1 |
+$981,404 |
4 |
Director, Other* |
17 May 2023, 17:05 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
10 Jun 2021 |
1 |
-$405,971 |
4 |
Director, Other* |
11 Jun 2021, 17:01 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
08 Jun 2021 |
2 |
-$5,397,810 |
4 |
Director, Other* |
10 Jun 2021, 19:00 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
07 Jun 2021 |
1 |
-$2,472,583 |
4 |
10%+ Owner |
09 Jun 2021, 18:51 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
03 Jun 2021 |
2 |
-$1,148,373 |
4 |
10%+ Owner |
07 Jun 2021, 16:30 |
| YMAB |
Y-mAbs Therapeutics, Inc. |
28 May 2021 |
2 |
-$1,152,648 |
4 |
10%+ Owner |
02 Jun 2021, 16:31 |